The Journal of
Clinical Psychiatry

Bipolar Disorder

Letter to the Editor August 1, 2001

Reboxetine-Induced Hypomania

Eduard Vieta ; Francesc Colom ; Anabel Martínez-Arán ; María Reinares ; Antonio Benabarre ; Barbara Corbella ; Cristóbal Gastó

J Clin Psychiatry 2001;62(8):655-656

Article Abstract

Letter to the Editor

Download Free PDF

This PDF is free for all visitors!

Save

Cite

INFORMATION FROM INDUSTRY

AUVELITY is an FDA-approved treatment for adults with MDD. Auvelity, is a rapid-acting antidepressant with a multimodal mechanism, targeting both glutamatergic and monoaminergic pathways. Learn more about how AUVELITY is thought to work and side effects. Please see Important Safety Information within this document and the full Prescribing Information.

Vol 86 • 2025 • Number 1

Read the Current Issue

Brief Report

Sex Differences in PTSD among US Military Veterans

Commentary

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Clinical and Practical Psychopharmacology

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Commentary

Evolving Care and Research Priorities in ADHD

Original Research

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Systematic Review

Efficacy and Safety of Memantine for Children and Adults with ADHD

View current Issue

Letter to the Editor

Antidepressant Effects of Combined Mood Stabilizers May Account for High Placebo Response Rates

June 22, 2021

Dr Terao comments on the methodology of a recent study evaluating citalopram for bipolar depression.

Takeshi Terao

Letter to the Editor

Antidepressants Added Nothing to Mood Stabilizers Alone: Reply to Terao

June 22, 2021

Dr Ghaemi responds to Dr Terao’s letter regarding a study of citalopram for bipolar depression.

S. Nassir Ghaemi

Letter to the Editor

Adjunctive Mood Stabilizers Are Not the Same As a Placebo-Only Arm in Bipolar Depression Trials: Reply to Terao

June 22, 2021

Dr Goldberg responds to Dr Terao’s letter regarding a study of citalopram for bipolar depression.

Joseph F. Goldberg

Reboxetine-Induced Hypomania

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

ELSEWHERE:

FOLLOW US:

Reboxetine-Induced Hypomania

Read the Current Issue

Sex Differences in PTSD among US Military Veterans

The Opioid Industry's Legacy: A Generation of Prescribed Suffering

Cannabis Use in Pregnancy and ASD or ADHD in Offspring

Evolving Care and Research Priorities in ADHD

Treatments and Treatment Predictors in Patients With SUDs and ADHD

Efficacy and Safety of Memantine for Children and Adults with ADHD

Related Articles

Antidepressant Effects of Combined Mood Stabilizers May Account for High Placebo Response Rates

Antidepressants Added Nothing to Mood Stabilizers Alone: Reply to Terao

Adjunctive Mood Stabilizers Are Not the Same As a Placebo-Only Arm in Bipolar Depression Trials: Reply to Terao

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles